Browsing by Author ABBADI, BRUNO L.
Showing rec. 1 to 8 of 8
Issue Date | Title | Author(s) |
2021 | Anti-tubercular profile of new selenium-menadione conjugates against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain and multidrug-resistant clinical isolates | RIBEIRO, RUAN C.B.; DE MARINS, DANIEL B.; DI LEO, IRIS, et al |
2021 | Effects of tafenoquine against active, dormant and resistant Mycobacterium tuberculosis | SIDRÔNIO, MARIA GABRIELLA S.; CASTELO BRANCO, ANA PAULA O.T.; ABBADI, BRUNO L., et al |
2021 | Effects of tafenoquine against active, dormant and resistant Mycobacterium tuberculosis | SIDRÔNIO, MARIA GABRIELLA S.; CASTELO BRANCO, ANA PAULA O.T.; ABBADI, BRUNO L., et al |
2017 | Functional, thermodynamics, structural and biological studies of in silico-identified inhibitors of Mycobacterium tuberculosis enoyl-ACP(CoA) reductase enzyme | MARTINELLI, LEONARDO K. B.; ROTTA, MARIANE; VILLELA, ANNE D., et al |
2017 | Functional, thermodynamics, structural and biological studies of in silico-identified inhibitors of Mycobacterium tuberculosis enoyl-ACP(CoA) reductase enzyme | MARTINELLI, LEONARDO K. B.; ROTTA, MARIANE; VILLELA, ANNE D., et al |
2018 | Is IQG-607 a Potential Metallodrug or Metallopro-Drug With a Defined Molecular Target in Mycobacterium tuberculosis? | ABBADI, BRUNO L.; RODRIGUES-JUNIOR, VALNÊS DA SILVA; DADDA, ADILIO DA SILVA, et al |
2020 | Nonclinical evaluation of IQG-607, an anti-tuberculosis candidate with potential use in combination drug therapy | RODRIGUES-JUNIOR, VALNÊS S.; VILLELA, ANNE D.; ABBADI, BRUNO L., et al |
2018 | Pre-clinical evaluation of quinoxaline-derived chalcones in tuberculosis | MURADÁS, THAÍS C.; ABBADI, BRUNO L.; VILLELA, ANNE D., et al |